Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial.
de la Rosa Oliva F, Meneses García A, Ruiz Calzada H, Astudillo de la Vega H, Bargalló Rocha E, Lara-Medina F, Alvarado Miranda A, Matus-Santos J, Flores-Díaz D, Oñate-Acuña LF, Gutiérrez-Salmeán G, Ruiz García E, Ibarra A. de la Rosa Oliva F, et al. Among authors: lara medina f. Nutr Hosp. 2019 Aug 26;36(4):769-776. doi: 10.20960/nh.2338. Nutr Hosp. 2019. PMID: 31192682 Free article. Clinical Trial. English.
Ocular metastases from breast carcinoma.
Mejía-Novelo A, Alvarado-Miranda A, Morales-Vázquez F, Gamboa-Vignole C, Núñez-Gómez R, Castañeda-Soto N, Dueñas-González A, Candelaria-Hernández M, Lara-Medina F. Mejía-Novelo A, et al. Med Oncol. 2004;21(3):217-21. doi: 10.1385/MO:21:3:217. Med Oncol. 2004. PMID: 15456948
[Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico].
Arce-Salinas C, Lara-Medina FU, Alvarado-Miranda A, Castañeda-Soto N, Bargalló-Rocha E, Ramírez-Ugalde MT, Pérez-Sánchez V, Rivera L, Gambo-Vignole C, Santamaría-Galicia J, Nieves-Casas RI, Morán-Muñoz H, Mohar-Betancourt A. Arce-Salinas C, et al. Rev Invest Clin. 2012 Jan-Feb;64(1):9-16. Rev Invest Clin. 2012. PMID: 22690524 Spanish.
Outcomes of Hispanic women with lymph-node positive, HER2 positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab in Mexico.
Villarreal-Garza C, Soto-Perez-de-Celis E, Sifuentes E, Ruano S, Baez-Revueltas B, Lara-Medina F, Arce-Salinas C, Alvarado-Miranda A, Chavarri-Guerra Y, Caro-Sanchez C, Castañeda-Soto N, Bargallo-Rocha E, Mohar A. Villarreal-Garza C, et al. Breast. 2015 Jun;24(3):218-23. doi: 10.1016/j.breast.2015.01.011. Epub 2015 Feb 16. Breast. 2015. PMID: 25698148
Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy.
Villarreal-Garza C, Bargallo-Rocha JE, Soto-Perez-de-Celis E, Lasa-Gonsebatt F, Arce-Salinas C, Lara-Medina F, Reynoso-Noverón N, Matus-Santos J, Cabrera P, Alvarado-Miranda A, Mohar A. Villarreal-Garza C, et al. Breast Cancer Res Treat. 2016 Jun;157(2):385-394. doi: 10.1007/s10549-016-3811-2. Epub 2016 May 17. Breast Cancer Res Treat. 2016. PMID: 27189008
Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer.
Villarreal-Garza C, Mohar A, Bargallo-Rocha JE, Lasa-Gonsebatt F, Reynoso-Noverón N, Matus-Santos J, Cabrera P, Arce-Salinas C, Lara-Medina F, Alvarado-Miranda A, Ramírez-Ugalde MT, Soto-Perez-de-Celis E. Villarreal-Garza C, et al. Clin Breast Cancer. 2017 Jun;17(3):e95-e102. doi: 10.1016/j.clbc.2016.11.007. Epub 2016 Nov 23. Clin Breast Cancer. 2017. PMID: 28065398
37 results